Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects
Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects
Recruiting · NCT07697560 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Recruiting | Phase 1 | 2026-07-29 | NCT07697560 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AnHorn Medicines Co. Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ICON Clinial Research Unit | Salt Lake City | United States | 1 |